José J. Naveja

Dr. José J. Naveja


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
OBOmar Yaxmehen Bello-Chavolla
Omar Yaxmehen Bello-Chavolla
JBJessica Paola Bahena-López
Jessica Paola Bahena-López
NANeftali Eduardo Antonio-Villa
Neftali Eduardo Antonio-Villa
AVArsenio Vargas-Vázquez
Arsenio Vargas-Vázquez
AGArmando González-Díaz
Armando González-Díaz
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas
BACKGROUND The SARS-CoV-2 outbreak poses challenge to healthcare systems due to high complication rates in patients with cardiometabolic diseases. Here, we identify risk factors and propose a clinical score to predict COVID-19 lethality, including specific factors for diabetes and obesity and its role in improving risk prediction. METHODS We obtained data of confirmed and negative COVID-19 cases and their demographic and health characteristics from the General Directorate of Epidemiology of Mexican Ministry of Health. We investigated specific risk factors associated to COVID-19 positivity and mortality and explored the impact of diabetes and obesity on modifying COVID-19 related lethality. Finally, we built a clinical score to predict COVID-19 lethality. RESULTS Among 177,133 subjects at May 18th, 2020, we observed 51,633 subjects with SARS-CoV-2 and 5,332 deaths. Risk factors for lethality in COVID-19 include early-onset diabetes, obesity, COPD, advanced age, hypertension, immunosuppression, and CKD; we observed that obesity mediates 49.5% of the effect of diabetes on COVID-19 lethality. Early-onset diabetes conferred an increased risk of hospitalization and obesity conferred an increased risk for ICU admission and intubation. Our predictive score for COVID-19 lethality included age ≥65 years, diabetes, early-onset diabetes, obesity, age <40 years, CKD, hypertension, and immunosuppression and significantly discriminates lethal from non-lethal COVID-19 cases (c-statistic=0.823). RESULTS Here, we propose a mechanistic approach to evaluate risk for complications and lethality attributable to COVID-19 considering the effect of obesity and diabetes in Mexico. Our score offers a clinical tool for quick determination of high-risk susceptibility patients in a first contact scenario.

26 February 2019 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
EDGAR LÓPEZ LÓPEZEDGAR LÓPEZ LÓPEZ
EDGAR LÓPEZ LÓPEZ
JNJosé J. Naveja
José J. Naveja
JMJose Medina-Franco
Jose Medina-Franco
Introduction: DataWarrior is open and interactive software for data analysis and visualization that integrates well-established and novel chemoinformatics algorithms in a single environment. Since its public release in 2014, DataWarrior has been used by research groups in universities, government, and industry. Areas covered: Herein, the authors discuss, in a critical manner, the tools and distinct technical features of DataWarrior and analyze the areas of opportunity. Authors also present the most common applications as well as emerging uses in research areas beyond drug discovery with an emphasis on multidisciplinary projects. Expert opinion: In the era of big data and data-driven science, DataWarrior stands out as a technology that combines prediction of physicochemical properties of pharmaceutical interest, cheminformatics calculations, multivariate data analysis, and interactive visualization with dynamic plots. The well-established chemoinformatics tools implemented in DataWarrior, as well as the innovative algorithms, make the technology useful and attractive as revealed by the increasing number of documented applications.

14 January 2019 in ACS Omega
Verified
Journal Article
Closed access
JNJosé J. Naveja
José J. Naveja
MVMartin Vogt
Martin Vogt
DSDagmar Stumpfe
Dagmar Stumpfe
JMJosé L. Medina-Franco
José L. Medina-Franco
Jürgen BajorathJürgen Bajorath
Jürgen Bajorath

16 July 2019 in Frontiers in Chemistry
Verified
Journal Article
Open access
JNJosé J. Naveja
José J. Naveja
JMJose Medina-Franco
Jose Medina-Franco
Herein we introduce the constellation plots as a general approach that merges different and complementary molecular representations to enhance the information contained in a visual representation and analysis of chemical space. The method is based on a combination of a sub-structure based representation and classification of compounds with a “classical” coordinate-based representation of chemical space. A distinctive outcome of the method is that organizing the compounds in analog series leads to the formation of groups of molecules, aka “constellations” in chemical space. The novel approach is general and can be used to rapidly identify, for instance, insightful and “bright” Structure-Activity Relationships (StARs) in chemical space that are easy to interpret. This kind of analysis is expected to be especially useful for lead identification in large datasets of unannotated molecules, such as those obtained through high-throughput screening. We demonstrate the application of the method using two datasets of focused inhibitors designed against DNMTs and AKT1.

24 November 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
MGMariana González-Medina
Mariana González-Medina
JNJosé J. Naveja
José J. Naveja
NSNorberto Sánchez-Cruz
Norberto Sánchez-Cruz
JMJose Medina-Franco
Jose Medina-Franco
Open chemoinformatic servers facilitate analysis of chemical space and structure–activity relationships.

3 August 2016 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
MGMariana González-Medina
Mariana González-Medina
FPFernando Daniel Prieto-Martínez
Fernando Daniel Prieto-Martínez
JNJosé J. Naveja
José J. Naveja
OMOscar Méndez-Lucio
Oscar Méndez-Lucio
TETamam El-Elimat
Tamam El-Elimat
JMJose Medina-Franco
Jose Medina-Franco
Aim: Fungi are valuable resources for bioactive secondary metabolites. However, the chemical space of fungal secondary metabolites has been studied only on a limited basis. Herein, we report a comprehensive chemoinformatic analysis of a unique set of 207 fungal metabolites isolated and characterized in a USA National Cancer Institute funded drug discovery project. Results: Comparison of the molecular complexity of the 207 fungal metabolites with approved anticancer and nonanticancer drugs, compounds in clinical studies, general screening compounds and molecules Generally Recognized as Safe revealed that fungal metabolites have high degree of complexity. Molecular fingerprints showed that fungal metabolites are as structurally diverse as other natural products and have, in general, drug-like physicochemical properties. Conclusion: Fungal products represent promising candidates to expand the medicinally relevant chemical space. This work is a significant expansion of an analysis reported years ago for a sma...